India seeks easier pharma access in Brazil, pushes to expand Mercosur trade pact

India seeks predictable regulations and easier market access for its pharmaceutical products. Discussions occurred at the India-Brazil Trade Monitoring Mechanism meeting in Brasilia. Both nations aim to expand the existing India-Mercosur trade agreement soon. Bilateral trade between India and Brazil is targeted to reach thirty billion dollars. This move aims to deepen economic ties and expand India's Latin American market presence.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/61n5FEv
via IFTTT

Read More

Healthcare ranks second in private credit deals as domestic funds dominate in H1 2026: EY report

India’s private credit market deployed $3.5 billion across more than 100 deals in H1 2026, broadly unchanged from $3.4 billion in H2 2025, according to EY.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QVWef32
via IFTTT

Read More

Jharkhand on high alert over Swine Flu; Health Minister directs hospitals to reserve beds, ramp up surveillance

Jharkhand Health Department is on high alert for potential H1N1 cases. Health Minister Irfan Ansari directed enhanced surveillance and hospital preparedness across the state. Ten additional beds are reserved in all medical college and district hospitals. Monitoring of Influenza-Like Illness and Severe Acute Respiratory Infection cases is intensified. Health teams will screen individuals at major transit points for immediate care.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EIXoHG0
via IFTTT

Read More

Park Medi World to expand hospital network across north India, add 1,450 beds by FY28

Park Medi World plans to add 1,450 beds by FY28, expanding its northern India network. The hospital chain focuses on Tier 1, 2, and 3 cities for efficient scaling. Acquisitions will target hospitals with 200-250 beds, expandable to 350. The company reported record net profit and revenue in FY26. Park Medi World is also adopting cleaner energy systems across its facilities.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/M7wtTK1
via IFTTT

Read More

Amrutanjan Health plans to set up 1 lakh direct chemist outlets in FY27

Amrutanjan Health Care plans to establish one lakh direct chemist outlets this fiscal year. The company achieved strong growth in pain management and women's hygiene categories during FY26. This expansion aims to increase brand availability beyond its traditional strongholds in the south and east. Amrutanjan also intends to relaunch its congestion-relief brand, Relief, in the current year. The company remains confident about demand in FY27, supported by its product portfolio.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iVRtT8w
via IFTTT

Read More

Is longevity the new flex? Why the new wellness status game is all about health data

Wellness has shifted from luxury retreats to daily personal management and longevity. Wearable technology now tracks health markers, encouraging consistent self-care habits. Fitness goals are increasingly performance-driven, moving beyond aesthetics and appearance. Nervous system regulation through breathwork and sound baths is gaining prominence. This new focus emphasizes consistent, unglamorous daily habits for long-term health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DMfNSWG
via IFTTT

Read More

Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard'

Maharashtra FDA withdrew its order to cancel Cipla Pharma's drug sale license after court intervention. The Bombay High Court criticized the regulator for acting in a high-handed and overboard manner. The FDA will now issue a fresh show cause notice to the company for a reasoned order. This action followed alleged irregularities in packaging, storage, and recall of specific tablets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8RsXVBK
via IFTTT

Read More